
¼¿ï´ëÇб³ ÀÓÇüÁØ ±³¼ö°¡ ¿¤½ººñ¾î(Elsevier)¿Í ½ºÅÄÆÛµå´ëÇб³°¡ °øµ¿ »êÃâÇÑ ¡®¼¼°è »óÀ§ 2% °úÇÐÀÚ(Top 2% Scientists)¡¯ ¸í´Ü¿¡ À̸§À» ¿Ã·È´Ù. À̹ø ¼±Á¤Àº 2025³â ´ÜÀÏ ¿¬µµ ±âÁØ ¿¬±¸ ¼º°ú¸¦ ºÐ¼®ÇÑ °á°ú·Î, Clinical Medicine(ÀÓ»óÀÇÇÐ) ºÐ¾ß, ¼¼ºÎ Àü°øÀÎ Nuclear Medicine & Medical Imaging(ÇÙÀÇÇÐ ¹× ÀÇÇпµ»ó) ºÐ¾ß¿¡¼ »óÀ§±Ç ¿¬±¸ÀÚ·Î Æò°¡µÆ´Ù.
°ø°³µÈ µ¥ÀÌÅÍ¿¡ µû¸£¸é ¼¼ºÎ ºÐ¾ß ³» ·©Å· 1042À§, H-Index 12, Hm-Index 4¸¦ ±â·ÏÇß´Ù. ÀÌ´Â ÇØ´ç ºÐ¾ß¿¡¼ ÀÏÁ¤ ±â°£ ÀÌ»ó ²ÙÁØÈ÷ ÀοëµÇ´Â ¿¬±¸¸¦ ´Ù¼ö ¹ßÇ¥ÇØ ¿ÔÀ½À» º¸¿©ÁØ´Ù.
Professor Hyung-jun Im from Seoul National University has been listed among the ¡°Top 2% Scientists,¡± a global researcher ranking jointly compiled by Elsevier and Stanford University. The 2025 single-year dataset evaluates research performance for a given year, and Prof. Im is recognized in the main field of Clinical Medicine, with a subfield focus on Nuclear Medicine & Medical Imaging.
According to the released data, Prof. Im holds a subfield rank of 1042, with an H-index of 12 and an Hm-index of 4, indicating a sustained record of publications that continue to be cited within his field.